Captopril - a breakthrough in treating diabetic renal disease

    loading  Checking for direct PDF access through Ovid

Abstract

Captopril can protect against renal deterioration in patients with insulin-dependent diabetes mellitus (IDDM) and overt nephropathy, according to a large, placebo-controlled study. This effect may be due to a property of captopril that is independent of the drug's recognised antihypertensive action. The implications for practice are considerable: by reducing the need for dialysis and kidney transplant procedures, captopril use could lead to vast cost savings and improved quality of life for tens of thousands of patients worldwide.

Related Topics

    loading  Loading Related Articles